Mucosal Immunomodulation
Mucosal Immunomodulation is a biological process that involves the targeted alteration of immune responses at mucosal surfaces to maintain homeostasis, prevent pathogenic inflammation, or enhance defense mechanisms through the regulated interaction of microbial, epithelial, and immune cell-derived signals.
84
Publications
5K
Citations
550
Authors
185
Institutions
Publications per year
2017–2026
22
84
Uptake through glycoprotein 2 of FimH+ bacteria by M cells initiates mucosal immune response
Koji Hase, Kazuya Kawano, Tomonori Nochi et al. · Nature · 2009 · 619 citations
Microbial metabolites control the thymic development of mucosal-associated invariant T cells
François Legoux, Déborah Bellet, Céline Daviaud et al. · Science · 2019 · 312 citations
Xin Shao, Chongzhen Sun, Xin Tang et al. · Journal of Agricultural and Food Chemistry · 2020 · 243 citations
1–5 of 84
550
4
h-index
4
h-index
4
h-index
4
h-index
4
h-index
1–5 of 550
185
National University of Tucumán
Tucumán, Argentina
4 h-index
4 publications
264 citations
Jagiellonian University
Krakow, Poland
4 h-index
41 publications
1.6K citations
University of Pennsylvania
Philadelphia, United States
3 h-index
16 publications
664 citations
The University of Tokyo
Tokyo, Japan
3 h-index
8 publications
2.7K citations

Consejo Nacional de Investigaciones Científicas y Técnicas
Buenos Aires, Argentina
3 h-index
7 publications
431 citations

Imperial College London
London, United Kingdom
3 h-index
11 publications
332 citations

Maastricht University Medical Centre
Maastricht, The Netherlands
2 h-index
4 publications
226 citations
University of Perugia
Perugia, Italy
2 h-index
7 publications
1.9K citations
1–8 of 185
8 publications · 422 citations
8
h-index
Repository · 5 publications · 152 citations
5
h-index
4 publications · 123 citations
4
h-index
3 publications · 73 citations
3
h-index
3 publications · 344 citations
3
h-index
1–5